Assessment of accuracy of axillary sentinel lymph node biopsy in medially located breast cancer using methylene blue injection technique: our institute experience

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

SENTINEL LYMPH NODE BIOPSY USING METHYLENE BLUE DYE IN EARLY BREAST CANCER. IS IT TRULY RELIABLE?

SUBAREOLAR VERSUS PERITUMORAL INJECTION OF METHYLENE BLUE FOR SENTINEL LYMPH NODE DETECTION IN CASES OF EARLY BREAST CANCER

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Efficacy of the Management of Node Negative Early Stage Breast Cancer Using 1% Methylene Blue in Sentinel Lymph Node Biopsy:prospective study, kasrAlaini University Hospital

Evaluation of the technique of endoscopic axillary sentinel lymph node biopsy in early-stage node-negative breast cancer

Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

Carbon nanoparticles versus patent blue dye for detection of sentinel lymph node in patients with early breast cancer